Health Care: Drugs

Novogen Ltd (NVGN: NASDAQ)

$1.85 -0.04 | -2.12%
02/11/16 - 03:59 PM ET
Company Income Statement
Jun 2015 Jun 2014 Jun 2013 Jun 2012
Sales 68.26K 81.91K 1.03M 1.55M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 68.26K 81.91K 1.03M 1.55M
Selling, General, and Administrative Expenses 2.95M 4.02M 2.64M 5.93M
Research & Development 4.55M 2.33M 237.54K 5.53M
Operating Income before D & A (EBITDA) -7.43M -6.27M -1.85M -9.91M
Depreciation & Amortization 441.02K 538.53K 311.77K 25.60K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 1.88M -186.42K 573.44K 959.58K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -5.99M -6.99M -1.59M -8.98M
Interest Expense 52.92K 673.17K 122.48K 0.00
Pre-Tax Income -6.04M -7.66M -1.71M -8.98M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest -128.09K -95.09K 228.26K -2.72M
Net Income From Continuing Operations -5.60M -7.13M -1.40M -8.95M
Net Income From Discontinued Operations 0.00 0.00 670.87K 7.57M
Net Income From Total Operations -5.60M -7.13M -728.40K -1.38M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -5.48M -7.03M -956.67K 1.34M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-5.60M -7.13M -1.40M -8.95M
Preferred Dividends
Net Income Available To Common -5.60M -7.13M -1.40M -8.95M
Basic EPS from Continuing Ops. -0.57 -1.12 -0.31 -1.51
Basic EPS from Discontinued Ops. 0.00 0.00 0.10 1.84
Basic EPS from Total Operations -0.57 -1.12 -0.21 0.33
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.57 -1.12 -0.21 0.33
Basic Normalized Net Income/Share -0.57 -1.12 -0.31 -1.51
EPS fr Continuing Ops. -0.57 -1.12 -0.31 -1.51
EPS fr Discontinued Ops 0.00 0.00 0.10 1.84
EPS fr Total Ops. -0.57 -1.12 -0.21 0.33
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.57 -1.12 -0.21 0.33
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.57 -1.12 -0.31 -1.51
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NVGN

Latest NVGN Headlines from TheStreet

More Financial News for NVGN

Press Releases for NVGN

See All Press Releases

Partner Headlines for NVGN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter